Compound Evidence File
#EC-2026-0807
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg)
Filed under Injectable Oils. The bureau holds 130 laboratory returns for this compound from 49 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
49 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Mar 2026 | 21 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 12 Apr 2026 | 15 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Feb 2026 | 15 Aug 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Feb 2026 | 13 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Jan 2026 | 3 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Jul 2026 | 6 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 10.0 | 10.0 | 9 Dec 2025 | 10 Aug 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Mar 2026 | 17 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 23 Feb 2026 | 14 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Jan 2026 | 28 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 13 Feb 2026 | 21 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Mar 2026 | 14 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 7 Apr 2026 | 1 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 10.0 | 26 Nov 2025 | 27 Apr 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 12 Jun 2026 | 1 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 9.9 | 2 Jun 2026 | 15 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Apr 2026 | 8 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 3 Jun 2026 | 12 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Mar 2026 | 2 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 26 May 2026 | 8 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 9.9 | 23 Apr 2026 | 13 Jun 2026 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 9.6 | 9.6 | 9.6 | 6 May 2025 | 6 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 9.3 | 8.2 | 10.0 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 9.2 | 8.4 | 10.0 | 23 May 2026 | 23 May 2026 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 9.2 | 9.2 | 9.2 | 9 Jun 2025 | 9 Jun 2025 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | X | 1 | 9.1 | 9.1 | 9.1 | 16 Mar 2025 | 16 Mar 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.9 | 7.7 | 9.9 | 25 May 2026 | 25 May 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 8.7 | 8.7 | 8.7 | 16 Mar 2025 | 16 Mar 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 2 | 8.6 | 7.4 | 9.7 | 20 Jun 2025 | 23 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 8 | 8.4 | 5.6 | 10.0 | 8 Jul 2025 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.1 | 7.0 | 9.4 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 8.0 | 7.9 | 8.0 | 24 May 2026 | 24 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 8.0 | 8.0 | 8.0 | 14 Jan 2025 | 14 Jan 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.8 | 7.8 | 7.8 | 2 Apr 2025 | 2 Apr 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 2 | 6.8 | 5.9 | 7.6 | 28 Mar 2025 | 17 May 2026 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 1 | 6.7 | 6.7 | 6.7 | 27 Feb 2025 | 27 Feb 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 6.5 | 6.5 | 6.5 | 16 Mar 2025 | 16 Mar 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.3 | 6.3 | 6.3 | 20 Jun 2025 | 20 Jun 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 | 8 Jul 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 5.5 | 5.5 | 5.5 | 17 Dec 2024 | 17 Dec 2024 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 4.6 | 4.6 | 4.6 | 2 Apr 2025 | 2 Apr 2025 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 4.4 | 4.4 | 4.4 | 25 Apr 2025 | 25 Apr 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 2 | 4.3 | 4.2 | 4.5 | 28 Mar 2025 | 21 May 2026 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 3.7 | 3.7 | 3.7 | 25 Apr 2025 | 25 Apr 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 2.3 | 2.3 | 2.3 | 9 Jun 2025 | 9 Jun 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 6 May 2025 | 6 May 2025 |
Open any subject to view the batch-level evidence for Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) alone.